Building on a previous study on recently validated MMP12 inhibitors [40], this study aims to characterize the anticancer potential of selected MMP12 inhibitor candidates, identify associated genomic biomarkers, and define the mechanistic consequences of MMP12 suppression in lung cancer. Here, MMP12 is linked to lung cancer.